MLMinyao Li

Minyao Li

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Minyao Li has a total of 11 co-authors. Here are the top co-authors by number of shared publications:

  • Huijuan Luo

    Department of Clinical Laboratory, Xiangya Hospital, Central South University, Changsha, Hunan, China

    1 shared publication
  • Jiazhen Wu

    Guangdong Provincial Key Laboratory of New Drug Development and Research of Chinese Medicine, Mathematical Engineering Academy of Chinese Medicine, Guangzhou University of Chinese Medicine, Guangzhou, China

    1 shared publication
  • Liping Chen

    Division of Biliary Surgery, Department of General Surgery, West China Hospital, Sichuan University, Chengdu, China

    1 shared publication
  • Nan Xu

    Shanghai Unicar-Therapy Bio-Medicine Technology Co, Ltd, Shanghai, China

    1 shared publication
  • Qiong-Hui Huang

    School of Chinese Medicine, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, N.T., Hong Kong SAR, PR China

    1 shared publication
  • Xiaoqi Huang

    Key Laboratory of Chinese Medicinal Resource from Lingnan (Ministry of Education), School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou 510006, China

    1 shared publication

Latest Publications

  • Open Access

    Protective Effect of Patchouli Alcohol Against High-Fat Diet Induced Hepatic Steatosis by Alleviating Endoplasmic Reticulum Stress and Regulating VLDL Metabolism in Rats

    by Xue Wu, Nan Xu, Minyao Li, Qionghui Huang, Jiazhen Wu, Yuxuan Gan, Liping Chen, Huijuan Luo, Yucui Li, Xiaoqi Huang, et al.

    Nonalcoholic fatty liver disease (NAFLD) is currently the most common chronic hepatic disorder worldwide. The earliest stage of NAFLD is simple steatosis, which is characterized by the accumulation of triglycerides in hepatocytes. Inhibition of steatosis is a potential treatment for NAFLD. Patchouli alcohol (PA) is an active component of Pogostemon cablin (Blanco) Benth. (Labiatae), which is a medicinal food in Asia countries and proved to possess hepatoprotective effect. This research aimed to investigate the effectiveness of PA against high fat diet (HFD)-induced hepatic steatosis in rats. In this study, male Sprague Dawley rats were fed a HFD for 4 weeks to induce NAFLD. Oral administration with PA significantly reduced pathological severity of steatosis in HFD-fed rats. It was associated with suppressing endoplasmic reticulum (ER) stress and regulating very low-density lipoprotein (VLDL) metabolism. Our data showed that PA treatment effectively attenuated ER stress by inhibiting the activation of protein kinase-like ER kinase (PERK), inositol-requiring transmembrane kinase/endoribonuclease 1 (IRE1), and activating transcription factor 6 (ATF6). Moreover, PA decreased hepatic VLDL uptake by suppressing very low-density lipoprotein receptor (VLDLR) expression. It also restored VLDL synthesis and export by increasing apolipoprotein B100 (apoB 100) secretion and microsomal triglyceride-transfer protein (MTP) activity. Taken together, PA exerted a protective effect on the treatment of NAFLD in HFD-fed rats and may be potential therapeutic agent acting on hepatic steatosis.